tiprankstipranks
Trending News
More News >
Viridian Therapeutics (VRDN)
NASDAQ:VRDN

Viridian Therapeutics (VRDN) Revenue

Compare
1,456 Followers

Viridian Therapeutics Revenue

Viridian Therapeutics had a revenue of 70.57M in the quarter ending Sep 30, 2025, with 93993.33%. This bring the company's revenue in the last twelve months to 70.79M, Decreased 23109.51%. In the fiscal year ending Dec 31, 2024, Viridian Therapeutics had annual revenue of 302.00K with -3.82% growth.
Revenue (ttm)
70.79M
Revenue Growth
23340.07%
P/S Ratio
9585.29
Revenue/Employee
$2,112
Employees
143
Market Cap
$2.89B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
302.00K-12.00K+96.18%
Dec 31, 2023
314.00K-1.46M+17.72%
Dec 31, 2022
1.77M-1.19M+59.80%
Dec 31, 2021
2.96M1.91M+282.19%
Dec 31, 2020
1.05M-3.41M+23.54%
Dec 31, 2019
4.46M-3.92M+53.20%
Dec 31, 2018
8.39M4.38M+209.49%
Dec 31, 2017
4.00M666.00K+119.96%
Dec 31, 2016
3.34M